Drug Information Association Logo
Corporate Tagline

NEW APPROACHES FOR MONITORING

Track:
Clinical Research and Development

Day & Time:
March 5, 9:00AM - 10:30AM

Session Number:
0501

Room Number:
Elicium 1

Type:
Session

Title:
NEW APPROACHES FOR MONITORING

Chair(s):
Peter Schiemann, PhD
Managing Partner
Widler & Schiemann Ltd, Switzerland

Description:
Participants will learn about the essentials of risk-based monitoring, what needs to be considered when switching from traditional monitoring to a risk-based approach and what the challenge are that need to be overcome when establishing a risk-based monitoring approach

Presentation(s) & Speaker(s):
Assessing Global CRA Workload and Utilisation
Kenneth A. Getz, MBA
Director of Sponsored Research, Tufts CSDD; Chairman, CISCRP
Tufts University, United States

Sites Unseen: Game plan for sponsors moving to risk-based monitoring
Rick Morrison
CEO
Comprehend Systems, United States

Risk-based Monitoring: Principles and Practical Implementation
Francois Beckers, PhD
Head of Biostatistics and Data Management
Glaxosmithkline Vaccines, Belgium

© 2013 DIA